Jubbonti (denosumab-bddz) - Sandoz
Cimerli (ranibizumab-eqrn) - Amneal, Formycon, Coherus Biosci, Teva
Hyrimoz (adalimumab-adaz) - Sandoz
Pyzchiva (ustekinumab-ttwe) - Samsung, Sandoz
https://www.globenewswire.com/news-release/2024/08/08/2926564/0/en/Sandoz-reports-second-quarter-sales-and-half-year-2024-results.html
 
Aug 8, 2024
 
Prev Next